Therapy Analysis & Statistics, July 2014 (p20)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: therapeutics, biotherapeutics, cancer therapeutics, more »

571-600 of about 2 300 reports

Purchase Reports From Reputable Market Research Publishers

 Macular Edema Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Macular Edema Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Macular Edema- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Therapy
  • Countries : United States, World
 Bacterial Sepsis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Bacterial Sepsis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Bacterial Sepsis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Hormone Replacement Therapy (HRT) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Hormone Replacement Therapy (HRT) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Hormone Replacement Therapy (HRT)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III ...

  • Industries : Therapy
  • Countries : United States
 Mixed Dyslipidemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Mixed Dyslipidemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Mixed Dyslipidemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Posterior Uveitis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Posterior Uveitis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Posterior Uveitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Ischemic Stroke Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Ischemic Stroke Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Ischemic Stroke- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Arthritis Pain Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Arthritis Pain Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Arthritis Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Therapy
  • Countries : United States, World
 Diffuse Posterior Uveitis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Diffuse Posterior Uveitis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Diffuse Posterior Uveitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline ...

  • Industries : Therapy
  • Countries : United States
 Liver Cirrhosis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Liver Cirrhosis Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Liver Cirrhosis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Meningeal Leukemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Meningeal Leukemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Meningeal Leukemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World
MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 ...

  • Industries : Therapy
  • Countries : Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark
Aurora A Kinase Inhibitors -Pipeline Insights, 2014

Aurora A Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Aurora A Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Therapy
Aurora B Kinase Inhibitors -Pipeline Insights, 2014

Aurora B Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Aurora B Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Therapy
Aurora C Kinase Inhibitors -Pipeline Insights, 2014

Aurora C Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Aurora C Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Therapy
CaM kinase Inhibitors (Ca2+/Calmodulin-Dependent Protein Kinase Inhibitors) -Pipeline Insights, 2014

CaM kinase Inhibitors (Ca2+/Calmodulin-Dependent Protein Kinase Inhibitors) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“CaM kinase Inhibitors (Ca2+/Calmodulin-Dependent Protein Kinase Inhibitors)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this ...

  • Industries : Therapy
Aurora Kinase Inhibitors -Pipeline Insights, 2014

Aurora Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Aurora Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Therapy
Bcr-Abl Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

Bcr-Abl Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Bcr-Abl Tyrosine Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Therapy
Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors -Pipeline Insights, 2014

Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Therapy
cFMS Kinase Inhibitors -Pipeline Insights, 2014

cFMS Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“cFMS Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Therapy
C-Raf Kinase Inhibitors -Pipeline Insights, 2014

C-Raf Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“C-Raf Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Therapy
Fyn Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

Fyn Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fyn Tyrosine Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Therapy
Lck Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

Lck Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Lck Tyrosine Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Therapy
Mitogen-Activated Protein (MAP) Kinase Inhibitors -Pipeline Insights, 2014

Mitogen-Activated Protein (MAP) Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Mitogen-Activated Protein (MAP) Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Therapy
Non-Receptor Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

Non-Receptor Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Non-Receptor Tyrosine Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Therapy
Serine/Threonine-Specific Protein Kinase Inhibitors -Pipeline Insights, 2014

Serine/Threonine-Specific Protein Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Serine/Threonine-Specific Protein Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Therapy
Src Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

Src Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Src Tyrosine Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Therapy
Wee1 Tyrosine Kinase inhibitors -Pipeline Insights, 2014

Wee1 Tyrosine Kinase inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Wee1 Tyrosine Kinase inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Therapy
Yes Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

Yes Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Yes Tyrosine Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Therapy
Echo Therapeutics, Inc. (Symbol:ECTE) SWOT Analysis, Strategy, Revenues and Profits

Echo Therapeutics, Inc. (Symbol:ECTE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • July 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
Addex Therapeutics, Ltd.. (ADXN) - Financial and Strategic SWOT Analysis Review

Addex Therapeutics, Ltd.. (ADXN) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • July 2014
  • by Global Data

Addex Therapeutics, Ltd.. (ADXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Therapy
About 700 reports

Download Unlimited Documents from Trusted Public Sources

Therapy Markets in the US

  • Clinical Application of Electrotherapeutic Modalities
  • September 2014
    6 pages
  • Therapy  

    Electrotherapy  

  • United States  

View report >

Vaccine Supply In Europe

September 2014

40 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Merck KGaA

Germany

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.